Effectiveness of rotavirus vaccination in Spain

 Abstract

With the aim of determining rotavirus vaccine effectiveness (RVVE) in Spain, from Oct-2008/Jun-2009, 467 consecutive children below 2 years old with acute gastroenteritis (AGE) were recruited using a pediatric research network (ReGALIP-www.regalip.org) that includes primary, emergency and hospital care settings. Of 467 enrolled children, 32.3% were rotavirus positive and 35.0% had received at least one dose of any rotavirus vaccine. RRVE to prevent any episode of rotavirus AGE was 91.5% (95% CI: 83.7%–95.6%). RVVE to prevent hospitalization by rotavirus AGE was 95.6% (85.6–98.6%). No differences in RVVE were found regarding the vaccine used. Rotavirus vaccines have showed an outstanding effectiveness in Spain.

Full Text Options
Article
Metrics
 Share
 Info
Pages
757 - 761
doi
10.4161/hv.7.7.15576
Type
Short Report
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Effectiveness of rotavirus vaccination in Spain